Description
IO No. 2 supports Canada’s continued focus on dealing with the significant risk that COVID-19 continues to pose to the health and safety of Canadians.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Explanatory note on new interim order to advance COVID-19 clinical trials | HTML | Open resource | |
| Explanatory note on new interim order to advance COVID-19 clinical trials | HTML | Open resource |